Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Androgens and Anabolic Steroids Market to Hit $124.18 Billion by 2030: Cognitive Market Research

Cognitive_Market_Research_Logo

News provided by

Cognitive Market Research

Mar 01, 2023, 06:00 ET

Share this article

Share toX

Share this article

Share toX

CHICAGO, March 1, 2023 /PRNewswire/ -- The Global Androgens and Anabolic Steroids Market size is valued at USD 52.63 Billion in 2022 and is projected to be USD 124.18 Billion by 2030, growing at a CAGR of 10.4% from 2023 to 2030, as per a recent report published by Cognitive Market Research. Androgens and anabolic steroids market in North America (especially in the U.S.) held the largest market share. For instance, Testosterone Gel 1.62% CIII, launched by Teva Pharmaceuticals in 2019, had an annual sale of around $911 million only in the U.S.

Major findings during the study of the Androgens and Anabolic Steroids Market:

  • Androgens and anabolic steroids are the synthetic derivatives of testosterone that are used in the treatment of hypogonadism to enhance the overall functionality of reproductive organs in an individual
  • Prolonged use of AAS may cause damage to the immune system. The common side effect associated with AAS is elevated blood pressure, especially in those with pre-existing hypertension
  • Oral segment has the highest share owing to its convenience and cost-effectiveness. Moreover, it is widely preferred by patients due to its non-invasiveness nature and is highly patient-compliance
  • However, the injectables mode of administration also held a significant share of 25.7% in the androgens and anabolic steroids market owing to its higher bioavailability. It is estimated that injectables will grow at the highest CAGR during the forecast period
  • Anabolic application accounts for the highest share in the market, which is attributed to its increased use in the treatment of hormonal problems, delayed puberty, and muscle loss. It is also used as a mainstay of therapy for hypoplastic anemias due to leukemia, kidney failure, or aplastic anemia
  • Online distribution of androgens and anabolic steroids is projected to grow at the highest CAGR in coming years. The revenue market share held by the online androgens and anabolic steroids market was 31.1% in 2022
  • North America Androgens and Anabolic Steroids Market dominate the overall market. High revenue in the North American region is primarily attributed to the high prevalence of hypogonadism and other hormonal problems among the population living in this region

Read Full Market Analysis Androgens and Anabolic Steroids: by Modes of Administration (Oral, Injectables, Topical, and Others); by Ingredients (Protein, Beta-alanine, Creatine, Caffeine, and Others); by Application (Anabolic, Androgenic, and Others); by Distribution Channel (Offline, and Online); by Region (North America, Europe, Asia Pacific, Latin America and Middle East, and Africa) Global Industry Analysis, COVID-19 Impact, and Industry Forecast, 2018-2030

Androgens and Anabolic Steroids Industry Statistics 2022:

Global Androgens and Anabolic Steroids Market

2022

Global Revenue (USD Billion)

52.63

CAGR (2023-2030)

10.4 %

Oral Mode of Administration Share

41.1 %

Protein Ingredients Share

29.8 %

Anabolic Application Share

42.4 %

Androgens and Anabolic Steroids Offline Distribution Channel Share

68.9 %

North America Androgens and Anabolic Steroids Market Share

36.1 %

What are the Growth, Drivers, and Opportunities for the Androgens and Anabolic Steroids Market?

Steep growth in the prevalence of hypogonadism is the foremost reason for the growth of the androgens and anabolic steroids market. Hypogonadism is an abnormal condition in which the testes or ovaries produce little or no hormone. It results in infertility and an increased risk of osteoporosis. The primary factor responsible for the rising occurrence of hypogonadism is the surging geriatric population across the globe. Hypogonadism in men is characterized by decreased libido, erectile dysfunction, decreased volume of ejaculation, and reduced bone density, among others. Hypogonadism in males and diseases such as type 2 diabetes mellitus, obesity, cardiovascular disease, and osteoporosis appear closely connected.

Moreover, change in lifestyle, unhealthy habits of smoking and consuming alcohol, along with stressful life, have also increased the risk factor for hormonal problems among people aged 25 to 40. Other factors responsible for market growth include the high prevalence of breast cancer and an increase in demand for weight gain and muscle gain, among others.

Check the Full Report, including Global, Regional, and Country Level Analysis:

https://www.cognitivemarketresearch.com/androgens-and-anabolic-steroids-market-report

How the COVID-19 Impacted Androgens and Anabolic Steroids Market?

Advent of COVID-19 had shown a negative effect on the revenue generated from the androgens and anabolic steroids market. This was majorly due to the disruption in the supply chain of raw materials and end products. Furthermore, R&D activities had also been hindered due to the unavailability of researchers during the pandemic.

Androgens and Anabolic Steroids Market Report Scope

Androgens and Anabolic Steroids Market – Modes of Administration Outlook (Revenue, USD Billion, 2018 – 2030)

  • Oral
  • Injectables
  • Topical
  • Others

Androgens and Anabolic Steroids Market – Ingredients Outlook (Revenue, USD Billion, 2018 – 2030)

  • Protein
  • Beta-alanine
  • Creatine
  • Caffeine
  • Others

Androgens and Anabolic Steroids Market - Application Outlook (Revenue, USD Billion, 2018 – 2030)

  • Anabolic
  • Androgenic
  • Others

Androgens and Anabolic Steroids Market- Distribution Channel Outlook (Revenue, USD Billion, 2018 – 2030)

  • Offline
  • Online

Androgens and Anabolic Steroids Market – Regional Outlook (Revenue, USD Billion, 2018 – 2030)

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, Rest of APAC)
  • Latin America (Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Saudi Arabia, Turkey, Egypt, Rest of MEA)

List of Key Players in the Androgens and Anabolic Steroids Market

  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Sanofi, GSK
  • Novartis AG
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Dr. Reddy's Laboratories Ltd.
  • Lupin
  • Cipla Inc.
  • Eli Lilly
  • AbbVie Inc.
  • For complete players list please click here: https://www.cognitivemarketresearch.com/androgens-and-anabolic-steroids-market-report#executive_summary

Related Reports on Androgens and Anabolic Steroids Market:

  • Global Corticosteroids Market are projected to hit USD 8.26 Billion by 2030

The global corticosteroids market is expected to reach USD 8.26 Billion by 2030 growing at a CAGR of 4.6%. Corticosteroid is a type of steroid hormone given as an anti-inflammatory medicine. It's a synthetic derivative of hormones used in a wide array of physiological processes, including stress response, carbohydrate metabolism, protein catabolism, immune response, regulation of inflammation, blood electrolyte levels, and behavior. The rising incidence of chronic illness drives the growth of the corticosteroids market.

  • Global Protein Supplement Market is expected to reach USD 12.41 Billion by 2030

The global protein supplement market is expected to reach USD 12.41 Billion by 2030 growing at a CAGR of 8.1%. The protein supplement market is gaining huge demand globally due to the rising number of health-conscious consumers. The number of people going to the gym has gradually increased, and it will continue to increase every year. The popularity of protein supplements among these people is very high as it fulfills daily nutritional requirements and helps them maintain their diet. Thus, the protein supplement market is growing at a significant rate across the globe.

Other Related Reports:

  • Global Erectile Dysfunction Treatment Market to reach $6.14 Billion by 2030, growing at an impressive CAGR of 6.3%
  • Global Opioids Market to hit $6.24 Billion by 2030, growing at an impressive CAGR of 2.6%
  • Global Sex Toys Market to be worth at $68.52 Billion by 2030, growing at an impressive CAGR of 8.1%
  • Global Condom Market to reach $10.38 Billion by 2030, growing at an impressive CAGR of 8.2%
  • Global Sex Doll Market to hit $52.47 Billion by 2030, growing at an impressive CAGR of 9.4%
  • Global Legal Steroids to reach $8.41 Billion by 2030, growing at a significant CAGR of 11.3%

Explore Other Cognitive Market Research's Healthcare Industry Report

About Cognitive Market Research

Cognitive Market Research has evolved as one of the leading market research and consulting firms providing services across multiple domains. Our team of researchers gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operating across the value chain. As a market research company, we gather information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.

Follow Us: LinkedIn | Twitter

Blog: Digital Tools that are Improving Post-Pandemic Market Research?

How Market Research is Adapting to the Post-Pandemic Changes?

How to Contact Us:
Nicolas Shaw
Global Sales Manager
Cognitive Market Research
Phone: USA: (+1) +1 312-376-8303 | Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785 | India: (+91) 983-496-8611
Email: [email protected] 
Web: https://www.cognitivemarketresearch.com

Athenaeum Subscription

Research Methodology

Logo: https://mma.prnewswire.com/media/1989016/Cognitive_Market_Research_Logo.jpg

SOURCE Cognitive Market Research

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.